مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

373
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

THE PREVALENCE OF HEPATITIS B AND C AMONG THALASSEMIA MAJOR PATIENTS IN GHAZVIN

Pages

  319-326

Abstract

 Regular BLOOD TRANSFUSIONs for patients with THALASSEMIA MAJOR have improved their overall survival, but carry a definite risk of being infected with blood born viruses especially HEPATITIS B and C. Now a days,it has remained as main health concern about these patients. In this study we tried to define the prevalence rate of HEPATITIS B and C and survey the related risk factors among a group of thalassemic patients in Ghazvin-Iran. We followed up all of thalassemics in Ghazvin, Iran(103 cases) and could access to 96 patients who were enrolled. The initial data were recorded and the sera were tested for HBV seromarkers, anti-HCV Ab and anti- HIV Ab using ELISA second generation and confirmed by RIBA second generation. Then samples were tested to measure hemoglobin and serum ferritin levels. 23 patients (24.2%) were anti-HCV Ab positive. One patient (1.1%) was HBs Ag positive and there was no anti-HIV positive case. Patients age, and transfusion duration were significantly higher in anti-HCV seropositive patients (P=0.01, P=0.03 repectively). Furthermore, HCV prevalence rate has significantly d(opped after applying anti-HCV Ab screening in blood donors (33.3% vs. 0%, P=0.002), and there was no new infected case thereafter. There were no significant associations between anti-HCV Ab seropositivity and history of splenectomy, vaccination against HBV, Patient and family history of hepatitis, and transfusion intervals. The mean of hemoglobin did not differ between two groups, but anti-HCV Ab positive patients had higher serum ferritin compared with anti-HCV negative patients (P=0.007). HEPATITIS C Prevalence rate is very high among thalassemics. Screening of blood donors seems to be able to decrease prevalence and incidence rate of HCY infection effectively. Furthermore, serum ferritin level seems to play a significant and independent role on liver injury in thalassemic patients.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    ALAVIA, S.M., HAJARIZADEH, B., DOROUDI, T., KAFAEI, J., YEKTAPARAST, B., SADRI, M., KAMALI, A., ESMAEILI, S., & GHODSI, F.. (2003). THE PREVALENCE OF HEPATITIS B AND C AMONG THALASSEMIA MAJOR PATIENTS IN GHAZVIN. KOWSAR MEDICAL JOURNAL, 7(part 4), 319-326. SID. https://sid.ir/paper/532119/en

    Vancouver: Copy

    ALAVIA S.M., HAJARIZADEH B., DOROUDI T., KAFAEI J., YEKTAPARAST B., SADRI M., KAMALI A., ESMAEILI S., GHODSI F.. THE PREVALENCE OF HEPATITIS B AND C AMONG THALASSEMIA MAJOR PATIENTS IN GHAZVIN. KOWSAR MEDICAL JOURNAL[Internet]. 2003;7(part 4):319-326. Available from: https://sid.ir/paper/532119/en

    IEEE: Copy

    S.M. ALAVIA, B. HAJARIZADEH, T. DOROUDI, J. KAFAEI, B. YEKTAPARAST, M. SADRI, A. KAMALI, S. ESMAEILI, and F. GHODSI, “THE PREVALENCE OF HEPATITIS B AND C AMONG THALASSEMIA MAJOR PATIENTS IN GHAZVIN,” KOWSAR MEDICAL JOURNAL, vol. 7, no. part 4, pp. 319–326, 2003, [Online]. Available: https://sid.ir/paper/532119/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    مرکز اطلاعات علمی SID
    strs
    دانشگاه امام حسین
    بنیاد ملی بازیهای رایانه ای
    کلید پژوه
    ایران سرچ
    ایران سرچ
    File Not Exists.
    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button